Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neuritis 1 Neoplasms 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Esthesioneuroblastoma, Olfactory 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 45 Radiotherapy 16 Carboplatin 15 Irinotecan 12 Carmustine 12 Bevacizumab 12 Filgrastim 10 Vincristine 9 Surgical Procedures, Operative 9 Magnetic Resonance Spectroscopy 9 Procarbazine 7 Peripheral Blood Stem Cell Transplantation 6 Imatinib Mesylate 6 Erlotinib Hydrochloride 6 temsirolimus 5 sargramostim 5 O(6)-benzylguanine 5 Lomustine 5 Flucytosine 5 Etoposide 5 Thiotepa 4 Sirolimus 4 Cyclophosphamide 4 aldesleukin 3 Thalidomide 3 Surveys and Questionnaires 3 Sunitinib 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Polymerase Chain Reaction 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Oligodendroglioma × Diffusion Tensor Imaging × Clear all

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡